Navigation Links
Anemia Triples Risk of Local Recurrence in Breast Cancer Patients
Date:4/3/2008

No differences seen in overall survival, metastasis when chemo triggered low red blood cell count

THURSDAY, April 3 (HealthDay News) -- Breast cancer patients who develop anemia during chemotherapy face almost three times the risk of a recurrence in the same area of the affected breast, new research suggests.

The Austrian study was a re-analysis of information from a clinical trial that took place in the 1990s. Importantly, the findings also indicated that anemia did alter overall survival or significantly increase the risk of cancer occurring in a patient's other breast or spreading elsewhere in the body. Anemia, a common side effect of chemotherapy, is a low red blood cell count that can cause fatigue and reduced quality of life.

"This study is definitely not aimed at changing current practice," said study author Dr. Peter Dubsky, of the Medical University of Vienna. "This is a retrospective analysis that has yielded quite controversial data. The conclusion from our study is aimed at experimental and clinical oncologic research. Anemia is associated with a high likelihood of tumor hypoxia [too little oxygen in the blood]."

The chemotherapy used in the study was a combination of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). The problems of anemia and related local recurrence are probably not limited to just this form of chemotherapy, noted Dr. Douglas Yee, director of the University of Minnesota Cancer Center. "I think this effect would be seen with any chemotherapy."

CMF is no longer commonly used in the treatment of breast cancer and has been replaced by other forms of chemotherapy such as taxanes, added Dr. Barry C. Lembersky, a clinical associate professor of medicine at the University of Pittsburgh School of Medicine. Also, there is a trend in breast cancer treatment to use chemotherapy less often, he said.

"Nowadays, there is a more selective use of chemotherapy, which tends t
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Panel Supports Anemia Drugs for Cancer Patients
2. FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients
3. UT Southwestern researchers investigate predictors for sickle-cell-anemia complications
4. Drugs used for cancer-associated anemia linked with increased risk of blood clots, death
5. Anemia Drugs for Cancer Patients Increase Death Risk
6. Anemia treatment may be a double-edged sword
7. FDA Reports New Risks Posed by Anemia Drugs
8. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
9. Evidence links anemia drugs with leukemic transformation in patients with primary myelofibrosis
10. New Kind of Stem Cells Reverse Sickle Cell Anemia
11. FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Anemia Triples Risk of Local Recurrence in Breast Cancer Patients
(Date:3/4/2015)... Diego (PRWEB) March 04, 2015 Alliance ... health and wellness for those in need in San ... fund local organizations through its Mission Support Grants program ... fourteen non-profit organizations applied for AHF’s Mission Support Grants ... involving AHF’s board of trustees and program committee, as ...
(Date:3/4/2015)... The Global Liquefied Petroleum Gas Market was valued ... to grow to $288.7 billion by 2019, at ... , Browse through the TOC of Global Liquefied ... trends, segments & forecasts., http://www.micromarketmonitor.com/market-report/liquid-petroleum-gas-reports-5046983367.html ... classified into source, application, and region. The sources ...
(Date:3/4/2015)... RapidScale, a global cloud services innovator, is attending ... 16th-18th. They are hosting Booth #1010 on the expo ... engineering executives in attendance to provide demos and discuss ... include William Hiatt, CTO; Jeff Richards, Cloud Delivery Manager; ... Support Manager. , RapidScale is also hosting two ...
(Date:3/4/2015)... According to a new report published by ... U.S. suffer from gastroesophageal reflux disease (GERD), more commonly ... control acid production, but these can have side effects. ... problem and lead to other uncomfortable digestive conditions. ... lower esophageal sphincter does not function properly. Anti-reflux devices ...
(Date:3/4/2015)... 04, 2015 The Conrad N. Hilton ... total of $6.9 million, which will help 151,000 people ... Burkina Faso. , The programs cover three years and ... focus on fixing water points in disrepair, addressing ... people to maintain water points and ensuring safe water ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4
... is available in French . , It,s a bit ... size of a pen nib that hovers over cell surfaces without ... solution is replaced with various molecules that can be selectively delivered ... device that researchers believe will serve as a powerful tool to ...
... 20, 2011) According to new Dutch research featured ... Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), ... tumor size but also in reducing the severity of ... many neuroendocrine cancers are incurable, they grow relatively slowly, ...
... Sept. 20 (HealthDay News) -- Black women who develop breast cancer ... in the other breast, and those who are diagnosed under age ... a more aggressive form, new research indicates. "When the ... more aggressive, more likely to be estrogen-receptor negative and it is ...
... Ohio People living in poor neighborhoods are at ... hospital than are people who live in wealthier neighborhoods, ... neighborhoods of differing socioeconomic status and out-of-hospital deaths caused ... 1992 and 2002. In each community, and among whites ...
... Conference Coordinating Committee (CCC) have selected Turning The Tide Together ... 2012), which will be held in Washington, D.C. from 22 ... reflects a unique moment in time, emphasizing that the AIDS ... recent scientific advances in HIV treatment and biomedical prevention, the ...
... , TUESDAY, Sept. 20 (HealthDay News) -- People affected ... those without it to develop schizophrenia, and those with ... epilepsy than people who are not schizophrenic, a new ... relationship between the two conditions may be due to ...
Cached Medicine News:Health News:Vacuum-like device makes cellular exploration easier 2Health News:Benefits of radionuclide therapy for neuroendocrine tumors 2Health News:Higher Risk of Second Breast Cancer Seen in Black Women 2Health News:Living in poor neighborhood a risk factor for out-of-hospital cardiac death 2Health News:Living in poor neighborhood a risk factor for out-of-hospital cardiac death 3Health News:Turning the Tide Together: AIDS 2012 theme selected 2Health News:Researchers Find Link Between Epilepsy, Schizophrenia Risk 2
(Date:3/4/2015)... from Indiana University School of Medicine are getting a ... a partnership with Lilly USA , ... Medicine are learning about drug development and how the ... roles in bringing new and innovative medicines to patients. ... and health system administrator, I recognize that there are ...
(Date:3/4/2015)... , March 4, 2015   InspireMD, Inc. ... in embolic protection systems ("EPS"), today announced that it ... to approximately 34 million shares of common stock and ... of common stock in a public offering.  The common ... of $0.40 per share, and each purchaser will receive ...
(Date:3/4/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... commercialization of proprietary compounded drug therapies, today reported that ... 2014 financial results on Thursday, March 12, 2015.  The ... EDT (1:30 p.m. PDT) on the same day to ... activities.  The conference call and webcast will be open ...
Breaking Medicine Technology:Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3
... 5, 2011 New data presented today at ... Scientific Sessions are the first to look at ... cardioverter defibrillators (ICDs) to detect restricted blood flow ... outside the hospital setting. Preliminary results from the ...
... Boston Scientific Corporation (NYSE: BSX ) today announced ... U.S. that covers its cardiac resynchronization therapy defibrillator (CRT-D) devices ... (PNS). "Under the program, implanting centers in the ... to replace a Boston Scientific COGNIS ® CRT-D device, ...
Cached Medicine Technology:New Data Provide First Look at Ability to Detect Life-Threatening Heart Problems in Some High-Risk Patients 2New Data Provide First Look at Ability to Detect Life-Threatening Heart Problems in Some High-Risk Patients 3Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation 2Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation 3Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation 4
The Liz Claiborne eyewear collection features feminine, classic, progressive friendly designs that meet the needs of today's women. The high quality frames are modern, but not trendy....
Inquire...
... a range of 18 Ophthalmic frames ... and producted to the very hightest ... super lightweight Titanium and Beta Titanium ... host of beautifully formed and innovative ...
... collection features a variety of colors ... of feminine styles designed with elegant ... men and women that are made ... as used in our fine timepieces, ...
Medicine Products: